A 3-D printed device comprising one or more structures, the structures comprising a plurality of magnetically responsive particles and one or more diblock or triblock copolymers; the diblock or triblock copolymers having an A-B, A-B-A, or A-B-C block-type structure in which the A-blocks and C-blocks are an aromatic-based polymer or an acrylate-based polymer and the B-blocks are an aliphatic-based polymer. These 3-D printed devices may be formed using a method that comprises providing a magnetic ink composition; applying the magnetic ink composition to a substrate in a 3-D solvent cast printing process to form one or more structures; and drying the one or more structures formed from the magnetic ink composition. The dried structures can exhibit one or more regions of magnetic permeability greater than 1.3×10.sup.−6 H/m.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

This disclosure relates to ethylene interpolymer compositions. Specifically, ethylene interpolymer products having: a Dilution Index (Y.sub.d) greater than 0; total catalytic metal 3.0 ppm; 0.03 terminal vinyl unsaturations per 100 carbon atoms, and; optionally a Dimensionless Modulus (X.sub.d) greater than 0. The disclosed ethylene interpolymer products have a melt index from about 0.3 to about 500 dg/minute, a density from about 0.869 to about 0.975 g/cm.sup.3, a polydispersity (M.sub.w/M.sub.n) from about 2 to about 25 and a CDBI.sub.50 from about 20% to about 97%. Further, the ethylene interpolymer products are a blend of at least two ethylene interpolymers; where one ethylene interpolymer is produced with a single-site catalyst formulation and at least one ethylene interpolymer is produced with a heterogeneous catalyst formulation.

The present invention relates to a method for evaluating an injection physical property of a plastic resin, and a polyethylene resin suitable for an injection molding process and, more particularly, to a novel method for evaluating an injection physical property of a plastic resin, which, when a particular plastic resin is processed by an injection process, can accurately derive injection suitability of the plastic resin and injection pressure in the injection process through a physical property value measured by using a resin specimen, and a polyethylene resin suitable for injection molding.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

Resorbable implants, coverings and receptacles comprising poly(butylene succinate) and copolymers thereof have been developed. The implants are preferably sterilized, and contain less than 20 endotoxin units per device as determined by the limulus amebocyte lysate (LAL) assay, and are particularly suitable for use in procedures where prolonged strength retention is necessary, and can include one or more bioactive agents. The implants may be made from fibers and meshes of poly(butylene succinate) and copolymers thereof, or by 3d printing molding, pultrusion or other melt or solvent processing method. The implants, or the fibers preset therein, may be oriented. These coverings and receptacles may be used to hold, or partially/fully cover, devices such as pacemakers and neurostimulators. The coverings, receptacles and implants described herein, may be made from meshes, webs, lattices, non-wovens, films, fibers, foams, molded, pultruded, machined and 3D printed forms.

A polyethylene composition comprising suitable for use in injection molding, the polyethylene composition comprising: from 2 wt. % to 25 wt. % of a high molecular weight component consisting of an ethylene/alpha-olefin copolymer, wherein the high molecular weight component has a density of from 0.910 g/cc to 0.971 g/cc, a melt index (12.16) of greater than 0.5 g/10 min to less than 1.5 g/10 min, a molecular weight distribution (Mw/Mn) of 6.0 to 20.0; from 75 wt. % to 98 wt. % a low molecular weight component consisting of an ethylene homopolymer or an ethylene/alpha-olefin copolymer, wherein the ethylene homopolymer or an and a molecular weight distribution (Mw/Mn) of less than 6.0; wherein the polyethylene composition has a shrinkage anisotropy that is less than the shrinkage anisotropy of the low molecular weight component.

The invention relates to an additive manufacturing process (3D printing) using particles having a meltable polymer. The meltable polymer comprises a thermoplastic polyurethane polymer which has a flowing temperature (intersection of E and E in the DMA) of 80 C. to <180 C. and a Shore A hardness according to DIN ISO 7619-1 of 50 Shore A and <85 Shore A and which, at a temperature T, has a melt volume rate (melt volume rate (MVR)) according to ISO 1133 of 5 to <15 cm.sup.3/10 min. The invention also relates to an item which can be obtained by means of the method.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.

The present invention relates to pharmaceutical dosage forms, for example to a tamper resistant dosage form including an opioid analgesic, and processes of manufacture, uses, and methods of treatment thereof.